AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29963053 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous bone marrow-derived mesenchymal stromal cells (MSCs) given at day 7 posttransplant
Number of subjects: 4
Study 29964145 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person consultation at public events (e.g., basketball game, county fair)
Number of subjects: 2185
Study 29964145 — intervention group
Group type: EXPERIMENTAL
Intervention: Online consultation via multimedia direction to an online website and social media advertising
Number of subjects: 2185
Study 29964145 — intervention group
Group type: EXPERIMENTAL
Intervention: Mail consultation
Number of subjects: 2185
Study 29964145 — intervention group
Group type: COMPARATOR
Intervention: Print advertisements in local papers
Number of subjects: 2185
Study 29965865 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective Laser Trabeculoplasty (SLT)
Number of subjects: 72
Study 29966429 — intervention group
Group type: COMPARATOR
Intervention: Resting heart rate of 70-79 bpm in men
Number of subjects: 233970
Study 29966429 — intervention group
Group type: COMPARATOR
Intervention: Resting heart rate of 80-89 bpm in women
Number of subjects: 233970
Study 29966429 — intervention group
Group type: COMPARATOR
Intervention: Resting heart rate >90 bpm
Number of subjects: 233970
Study 29966800 — intervention group
Group type: EXPERIMENTAL
Intervention: Crizotinib 250 mg orally twice daily continuously (3-week cycles)
Number of subjects: 0
Study 29966800 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (pemetrexed 500 mg/m2 intravenously)
Number of subjects: 0
Study 29966863 — intervention group
Group type: EXPERIMENTAL
Intervention: Lobaplatin 25-50 mg/m² concurrent with IMRT
Number of subjects: 17
Study 29967236 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone replacement therapy
Number of subjects: 0
Study 29967236 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 0
Study 29967357 — intervention group
Group type: EXPERIMENTAL
Intervention: Jackhammer esophagus (JE) diagnosis
Number of subjects: 37
Study 29967357 — intervention group
Group type: EXPERIMENTAL
Intervention: GERD positive diagnosis
Number of subjects: 37
Study 29967357 — intervention group
Group type: EXPERIMENTAL
Intervention: Acid hypersensitive esophagus diagnosis
Number of subjects: 37
Study 29967357 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical parameters differentiation
Number of subjects: 37
Study 29967357 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevalence of JE
Number of subjects: 37
Study 29967357 — intervention group
Group type: EXPERIMENTAL
Intervention: True GERD diagnosis
Number of subjects: 37
Study 29967588 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 29967693 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophrenia Coping Oral Health Profile (SCOOHP)
Number of subjects: 20
Study 29967693 — intervention group
Group type: EXPERIMENTAL
Intervention: SCOOHP scale with 23 items (15 items for positive coping and 8 items for negative coping)
Number of subjects: 20
Study 29968240 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery combined with radiation (ART group)
Number of subjects: 178
Study 29968240 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (NORT group)
Number of subjects: 178
Study 29968431 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin plus pioglitazone (30 mg/day)
Number of subjects: 41
Study 29968431 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin (20 mg/day)
Number of subjects: 41
Study 29968437 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH and home-based exercise group (D+Ex)
Number of subjects: 85
Study 29968437 — intervention group
Group type: COMPARATOR
Intervention: Advice-only comparison group (C)
Number of subjects: 85
Study 29968501 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular therapy
Number of subjects: 1200
Study 29968501 — intervention group
Group type: EXPERIMENTAL
Intervention: Bypass grafting
Number of subjects: 1200
Study 29968501 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral artery patchplasty
Number of subjects: 1200
Study 29968501 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative treatment
Number of subjects: 1200
Study 29968501 — intervention group
Group type: COMPARATOR
Intervention: Bypass surgery
Number of subjects: 1200
Study 29968501 — intervention group
Group type: COMPARATOR
Intervention: Endovascular revascularization
Number of subjects: 1200
Study 29969456 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-taxed sugary soft drinks
Number of subjects: 2836
Study 29969456 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-taxed soft drinks
Number of subjects: 2836
Study 29969456 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugary soft drinks
Number of subjects: 2836
Study 29969456 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall impact of the tax
Number of subjects: 2836
Study 29969456 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup analyses
Number of subjects: 2836
Study 29969586 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressed women
Number of subjects: 732
Study 29969916 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-step simplified Tai-chi training programme for 16 weeks
Number of subjects: 26
Study 29969916 — intervention group
Group type: COMPARATOR
Intervention: Recreational activities organized by the centres
Number of subjects: 26
Study 29969990 — intervention group
Group type: EXPERIMENTAL
Intervention: ACQUIRE-ICD care innovation (comprehensive interactive eHealth intervention)
Number of subjects: 478
Study 29969990 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 478
Study 29969998 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiography screening conducted by trained local radiographers
Number of subjects: 1102
Study 29970005 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic medication review based on the RASP list
Number of subjects: 59
Study 29970005 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 59
Study 29970046 — intervention group
Group type: EXPERIMENTAL
Intervention: Training provided to increase moderate-to-vigorous physical activity (MVPA) during the program by extending scheduled time for activity opportunities and modifying games.
Number of subjects: 20
Study 29970046 — intervention group
Group type: EXPERIMENTAL
Intervention: Programs that gained MVPA (avg. +5.5 to +10.1 min MVPA) modified their program in supportive ways.
Number of subjects: 20
Study 29970050 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerometer-determined physical activity (PA) monitoring during school hours
Number of subjects: 676
Study 29970050 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerometer-determined physical activity (PA) monitoring during weekdays
Number of subjects: 676
Study 29970050 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerometer-determined physical activity (PA) monitoring during weekend days
Number of subjects: 676
Study 29970050 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerometer-determined physical activity (PA) monitoring during afternoon hours
Number of subjects: 676
Study 29970050 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerometer-determined physical activity (PA) monitoring during total leisure time
Number of subjects: 676
Study 29970050 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerometer-determined physical activity (PA) monitoring over a 7-day week
Number of subjects: 676
Study 29970050 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring period for achieving reliability of 0.80 across all domains
Number of subjects: 676
Study 29970063 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-collected HPV tests during community health campaign
Number of subjects: 255
Study 29970107 — intervention group
Group type: EXPERIMENTAL
Intervention: Vocational Rehabilitation Programme (VRP)
Number of subjects: 0
Study 29970108 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-minute walk test (6MWT)
Number of subjects: 0
Study 29970172 — intervention group
Group type: EXPERIMENTAL
Intervention: SQUEAC conjugate Bayesian analysis
Number of subjects: 0
Study 29970172 — intervention group
Group type: COMPARATOR
Intervention: Two-stage cluster survey
Number of subjects: 0
Study 29970319 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 mg of soy-derived phosphatidic acid (PA)
Number of subjects: 16
Study 29970319 — intervention group
Group type: COMPARATOR
Intervention: Rice-flour placebo (PL)
Number of subjects: 16
Study 29970357 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phone delivered intervention based on Acceptance and Commitment Therapy (ACT)
Number of subjects: 251
Study 29970389 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injections on days 0, 30, 60, and 90, plus hyaluronic acid five times per day
Number of subjects: 30
Study 29970389 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronic acid five times per day
Number of subjects: 30
Study 29971158 — intervention group
Group type: EXPERIMENTAL
Intervention: 67% sodium bicarbonate dentifrice
Number of subjects: 56
Study 29971158 — intervention group
Group type: COMPARATOR
Intervention: Control dentifrice
Number of subjects: 56
Study 29971569 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-rated apathy scores
Number of subjects: 35
Study 29971569 — intervention group
Group type: EXPERIMENTAL
Intervention: Informant-rated apathy scores
Number of subjects: 35
Study 29971569 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-rated depression scores
Number of subjects: 35
Study 29971569 — intervention group
Group type: EXPERIMENTAL
Intervention: Informant-rated depression scores
Number of subjects: 35
Study 29971962 — intervention group
Group type: COMPARATOR
Intervention: Bioelectrical impedance analysis (BIA) measuring Phase Angle (PA) and levels of extra-/intracellular water (ECW; ICW)
Number of subjects: 38
Study 29971962 — intervention group
Group type: COMPARATOR
Intervention: Bioelectrical impedance analysis (BIA) measuring ICW levels
Number of subjects: 38
Study 29971962 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioelectrical impedance analysis (BIA) measuring correlation between PA and ICW
Number of subjects: 38
Study 29971962 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioelectrical impedance analysis (BIA) measuring ECW/ICW ratio
Number of subjects: 38
Study 29972089 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone furoate/vilanterol (FF/VI) 100[200]/25 µg
Number of subjects: 1264
Study 29972089 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone furoate/vilanterol (FF/VI)
Number of subjects: 1264
Study 29972089 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate/salmeterol (FP/Salm)
Number of subjects: 1264
Study 29972716 — intervention group
Group type: EXPERIMENTAL
Intervention: ASP8273 300 mg
Number of subjects: 121
Study 29972716 — intervention group
Group type: EXPERIMENTAL
Intervention: ASP8273
Number of subjects: 121
Study 29972871 — intervention group
Group type: EXPERIMENTAL
Intervention: rhPTH(1-84)
Number of subjects: 13
Study 29973147 — intervention group
Group type: EXPERIMENTAL
Intervention: Costs in the highest quintile by country and index event diagnosis
Number of subjects: 12922
Study 29973147 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean length of stay
Number of subjects: 12922
Study 29973147 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest-cost countries
Number of subjects: 12922
Study 29973153 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylbutyrate (PBA) 500mg twice daily for 8 weeks
Number of subjects: 31
Study 29973204 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipilimumab (10 mg/kg IV every 3 weeks for 2 doses)
Number of subjects: 0
Study 29973227 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegvaliase treatment
Number of subjects: 68
Study 29973233 — intervention group
Group type: EXPERIMENTAL
Intervention: Tubular cellular injury (induced by ischemia-reperfusion injury)
Number of subjects: 20
Study 29973233 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouse model of kidney warm ischemia-reperfusion injury
Number of subjects: 20
Study 29973233 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical study subjects post tubular cell injury
Number of subjects: 20
Study 29973256 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of 25% silver nitrate (AgNO3)
Number of subjects: 0
Study 29973256 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium fluoride (NaF) varnish with functionalized tricalcium phosphate (fTCP)
Number of subjects: 0
Study 29973256 — intervention group
Group type: COMPARATOR
Intervention: Control group not explicitly mentioned
Number of subjects: 0
Study 29973911 — intervention group
Group type: EXPERIMENTAL
Intervention: Firearm use
Number of subjects: 0
Study 29973911 — intervention group
Group type: COMPARATOR
Intervention: No firearm use
Number of subjects: 0
Study 29974390 — intervention group
Group type: EXPERIMENTAL
Intervention: Fallers with upper-limb fracture
Number of subjects: 80
Study 29974390 — intervention group
Group type: COMPARATOR
Intervention: Fallers without fracture
Number of subjects: 80
Study 29974618 — intervention group
Group type: EXPERIMENTAL
Intervention: iGlarLixi (simultaneous administration of insulin glargine 100 U and lixisenatide)
Number of subjects: 0
Study 29974618 — intervention group
Group type: COMPARATOR
Intervention: Sequential iGlar + Lixi (sequential administration of insulin glargine and lixisenatide)
Number of subjects: 0
Study 29974618 — intervention group
Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 0
Study 29975012 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients without widespread pain (WP) receiving biologic or conventional synthetic disease-modifying antirheumatic drugs (DMARDs)
Number of subjects: 69
Study 29975012 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with baseline color Doppler activity (n = 42 [61%]) receiving biologic or conventional synthetic DMARDs
Number of subjects: 69
Study 29975012 — intervention group
Group type: COMPARATOR
Intervention: Patients with widespread nonarthritic pain (WP) receiving biologic or conventional synthetic DMARDs
Number of subjects: 69
Study 29976121 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Mini-Mental State (3MS) examination
Number of subjects: 19300
Study 29976121 — intervention group
Group type: EXPERIMENTAL
Intervention: Factor analysis of 3MS scores
Number of subjects: 19300
Study 29976172 — intervention group
Group type: EXPERIMENTAL
Intervention: High performance functional assay for individual radiosensitivity (IRS)
Number of subjects: 222
Study 29976218 — intervention group
Group type: EXPERIMENTAL
Intervention: valanafusp alpha (1, 3, or 6 mg/kg) administered via weekly intravenous infusion for 52 weeks
Number of subjects: 11
Study 29976227 — intervention group
Group type: COMPARATOR
Intervention: Traditional occlusive dressing
Number of subjects: 550
Study 29976227 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquacel Surgical
Number of subjects: 550
Study 29976287 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 11121
Study 29976297 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 29976503 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiation therapy (CCRT)
Number of subjects: 37
Study 29976650 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation (NIV)
Number of subjects: 426
Study 29977205 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led intervention to enhance medication adherence
Number of subjects: 0
Study 29977205 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 0
Study 29977284 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of serum TFF3 and pepsinogen
Number of subjects: 281
Study 29977284 — intervention group
Group type: COMPARATOR
Intervention: TFF3 alone
Number of subjects: 281
Study 29977284 — intervention group
Group type: COMPARATOR
Intervention: Pepsinogen test alone
Number of subjects: 281
Study 29977593 — intervention group
Group type: EXPERIMENTAL
Intervention: HENRY programme (8-week programme delivered to parents)
Number of subjects: 120
Study 29977593 — intervention group
Group type: COMPARATOR
Intervention: Standard care (usual provision of services within children's centres)
Number of subjects: 120
Study 29977603 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial phototherapy using GLO™ Science device, emitting light at 475 nm and 3 W, applied in 2 cycles of 8 min
Number of subjects: 31
Study 29977603 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial phototherapy
Number of subjects: 31
Study 29978216 — intervention group
Group type: EXPERIMENTAL
Intervention: BIND-014 (60 mg/m2 intravenously on day 1 of 21-day cycles in combination with prednisone)
Number of subjects: 42
Study 29978298 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided left lateral TAP block combined with RS block (15 ml of 0.5% ropivacaine for TAP and 10 ml of 0.5% ropivacaine for RS)
Number of subjects: 30
Study 29978342 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous platelet lysate applied as eye drops four times a day
Number of subjects: 10
Study 29979092 — intervention group
Group type: EXPERIMENTAL
Intervention: Objective evidence of myocardial ischemia in T2MI patients
Number of subjects: 1640
Study 29979092 — intervention group
Group type: COMPARATOR
Intervention: Subjective criteria for diagnosing T2MI
Number of subjects: 1640
Study 29979355 — intervention group
Group type: EXPERIMENTAL
Intervention: Urgency FI
Number of subjects: 46
Study 29979355 — intervention group
Group type: COMPARATOR
Intervention: Passive FI
Number of subjects: 46
Study 29979745 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialized Rehabilitation Centers (SRC)
Number of subjects: 782
Study 29979745 — intervention group
Group type: COMPARATOR
Intervention: Residential Facilities (RF)
Number of subjects: 782
Study 29980220 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold snaring polypectomy
Number of subjects: 4258
Study 29980220 — intervention group
Group type: COMPARATOR
Intervention: Hot snaring polypectomy
Number of subjects: 4258
Study 29980242 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily second-hand tobacco smoke (SHS) exposure
Number of subjects: 8850
Study 29980242 — intervention group
Group type: COMPARATOR
Intervention: Occasional second-hand tobacco smoke (SHS) exposure
Number of subjects: 8850
Study 29980242 — intervention group
Group type: COMPARATOR
Intervention: Infrequent second-hand tobacco smoke (SHS) exposure among men
Number of subjects: 8850
Study 29980242 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily second-hand tobacco smoke (SHS) exposure among women
Number of subjects: 8850
Study 29980242 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily second-hand tobacco smoke (SHS) exposure among men
Number of subjects: 8850
Study 29980490 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFIRI + Aflibercept (4 mg/kg body weight delivered intravenously every 2 weeks for a maximum of 12 cycles, followed by aflibercept maintenance)
Number of subjects: 73
Study 29980490 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFIRI + Aflibercept
Number of subjects: 73
Study 29980523 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative flow ratio (QFR)
Number of subjects: 329
Study 29980523 — intervention group
Group type: COMPARATOR
Intervention: 2-dimensional quantitative coronary angiography (2D-QCA)
Number of subjects: 329
Study 29980524 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter-related thrombosis
Number of subjects: 3032
Study 29980524 — intervention group
Group type: EXPERIMENTAL
Intervention: Venous thromboembolism other than catheter-related
Number of subjects: 3032
Study 29980524 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors for catheter-related thrombosis
Number of subjects: 3032
Study 29980524 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors for venous thromboembolism other than catheter-related
Number of subjects: 3032
Study 29980535 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg β3-AR agonist mirabegron
Number of subjects: 12
Study 29980535 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg β3-AR agonist mirabegron
Number of subjects: 12
Study 29980535 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 29980537 — intervention group
Group type: EXPERIMENTAL
Intervention: HDC/IL2 (histamine dihydrochloride and low-dose interleukin-2)
Number of subjects: 81
Study 29980537 — intervention group
Group type: COMPARATOR
Intervention: Control cohort (not receiving HDC/IL2)
Number of subjects: 81
Study 29980542 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective CT fluoroscopy transforaminal epidural steroid (arm 1)
Number of subjects: 0
Study 29980542 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective CT fluoroscopy transforaminal epidural saline (arm 2)
Number of subjects: 0
Study 29980542 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 days tapering dose of oral steroids (arm 3)
Number of subjects: 0
Study 29980542 — intervention group
Group type: COMPARATOR
Intervention: Sham epidural and oral placebo control (arm 4)
Number of subjects: 0
Study 29980542 — intervention group
Group type: EXPERIMENTAL
Intervention: All arms (1-4)
Number of subjects: 0
Study 29980544 — intervention group
Group type: EXPERIMENTAL
Intervention: Improving Care for Cardiovascular Disease in China-AF programme
Number of subjects: 28801
Study 29980548 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychiatric assessments (Mini International Neuropsychiatric Interview, Kiddie Schedule for Affective Disorders and Schizophrenia -Present and Lifetime Version, Positive and Negative Syndrome Scale, Scale for the Assessment of Negative Symptoms)
Number of subjects: 0
Study 29980548 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurocognitive evaluations (IQ, Trail Making Test A/B, verbal fluency)
Number of subjects: 0
Study 29980548 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic analysis using next-generation sequencing on trio (mother, father, and child)
Number of subjects: 0
Study 29980572 — intervention group
Group type: EXPERIMENTAL
Intervention: Telomere length (TL) in peripheral blood (PB) cells
Number of subjects: 0
Study 29980572 — intervention group
Group type: EXPERIMENTAL
Intervention: BCR-ABL
Number of subjects: 0
Study 29980655 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 1 to Day 7
Number of subjects: 63
Study 29980655 — intervention group
Group type: COMPARATOR
Intervention: Day 1
Number of subjects: 63
Study 29980656 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0